Electromyographic Calibration Guided by Depth of Anesthesia (CELESTE)

May 10, 2026 updated by: Manfred Blobner, University Hospital Ulm

Does Calibration of Electromyography Guided by State Entropy Improve Measurement Precision

The goal of the CELESTE study is to evaluate whether calibration of EMG is needed for reliable interpretation of neuromuscular function and if so, to identify the minimal necessary depth of anesthesia.

Study Overview

Status

Completed

Detailed Description

Neuromuscular monitoring is used to document neuromuscular function intra-operatively. Failure to restore neuromuscular function prior to extubation results in residual neuromuscular blockade which is associated with increased postoperative morbidity and mortality. It is essential to document baseline neuromuscular function before administration of the neuromuscular blocking agent. However, during anesthesia induction, neuromuscular monitoring is rarely calibrated due to its time-consuming nature coinciding with the patients' loss of consciousness.

The CELESTE trial is a randomized, prospective, observational proof-of-concept study. We plan to enroll sixty adult participants scheduled for elective non-cardiac surgery requiring general anesthesia with moderate neuromuscular blockade. Participants will be randomized into three electromyography (EMG) calibration groups: based on state entropy ("depth of anesthesia"), group 1 will receive "analgesic calibration", group 2 "sedated calibration", and group 3 "no calibration". Participants will be randomly allocated to receive calibration at a certain depth of anesthesia. All participants will receive a standard EMG performed on the contralateral arm. Standard EMG will be calibrated at state entropy of 50.

Study Type

Observational

Enrollment (Actual)

66

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Baden-Wurttemberg
      • Ulm, Baden-Wurttemberg, Germany, 89073
        • University Hospital Ulm

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The CELESTE study will be performed in adult patients scheduled for elective non-cardiac surgery requiring general anesthesia and moderate neuromuscular blockade.

Description

Inclusion Criteria:

  • signed informed written consent
  • BMI 17.5-30 kg/m^2
  • ASA <= 3
  • supine positioning during surgery with intraoperative access to both arms
  • absence of allergy to muscle relaxants and reversal agents
  • absence of neuromuscular disease

Exclusion Criteria:

  • ambulatory patients for whom discharge is planned within 12 hours of anaesthesia
  • patients undergoing minor surgical
  • procedures scheduled outside the operating room
  • patients who are endotracheally intubated prior to surgery
  • pregnancy
  • indication for rapid sequence induction
  • patients undergoing arm surgery
  • patients with preceding injuries impairing muscle or nerve function of the arm (e.g., finger amputation)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Analgesic calibration
Participants will receive calibration of electromyography at state entropy of 90.
Sedated calibration
Calibration will be started at state entropy of 70.
No calibration
Participants will not receive calibration of electromyography. Measurements will start simultaneously to the standard electromyography with a default current of 60mA at state entropy of 50.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Precision of Train-of-four measurements
Time Frame: intraoperative
repeatability coefficient
intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recall of calibration
Time Frame: postoperative day 1
postoperative day 1
Discomfort with calibration
Time Frame: postoperative day 1
postoperative day 1
Tolerance interval of Train-of-four ratios
Time Frame: intraoperative
intraoperative
Agreement of EMG calibration group Train-of-four and standard Train-of-four
Time Frame: intraoperative
Agreement of both calibration group EMG and standard EMG regarding the decision whether complete neuromuscular recovery is given based on a Train-of-four ratio of >0.9 or >0.95, respectively.
intraoperative
Time difference between calibration group Train-of-four and standard Train-of-four to complete recovery
Time Frame: intraoperative
Time difference between calibration group EMG and the standard EMG reaching a Train-of-four ratio >0.9 or >0.95, respectively.
intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Manfred Blobner, MD PhD, Department of Anesthesiology and Intensive Care Medicine, University of Ulm, Ulm, Germany.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 16, 2022

Primary Completion (Actual)

May 31, 2023

Study Completion (Actual)

May 31, 2023

Study Registration Dates

First Submitted

May 27, 2021

First Submitted That Met QC Criteria

June 1, 2021

First Posted (Actual)

June 2, 2021

Study Record Updates

Last Update Posted (Actual)

May 13, 2026

Last Update Submitted That Met QC Criteria

May 10, 2026

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CELESTE-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe